Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0164


Standard and new treatment strategy to prevent melanoma recurrence.

Prof. Odysseas Zoras, M.D, PhD.

Affiliation: Professor Odysseas Zoras, Department of General Surgery, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Crete, Greece.


Since there is no abstract available we provide the first paragraph.

Cancer biology and genetics advances have provided highlights in an improvement in understanding why some patients with melanoma recur to current treatment modality. One possible explanation is the presence of mutations in the BRAF gene. However, molecular mechanisms underlying recurrence are much more complex and sophisticated research is needed to understand the full story of treatment failure and patient's death [1, 2].

(Citation: Gastric & Breast Cancer 2011; 10(2): 100-102)



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 15 March 2011